Corrigendum: Airway T cells protect against RSV infection in the absence of antibody (Mucosal Immunology (2018) 11 (249-256) DOI: 10.1038/mi.2017.46);Airway T cells protect against RSV infection in the absence of antibody

Mucosal Immunology

Volumn 11, Issue 1, 2018, Pages 249-256

  Kinnear, E ^a   Lambert, L ^a   McDonald, J U ^a   Cheeseman, H M ^a   Caproni, L J ^b   Tregoning, J S ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Morelands and Riverdale Buildings   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; RESPIRATORY SYNCYTIAL VIRUS ANTIBODY; TUMOR NECROSIS FACTOR; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RESPONSE; DNA IMMUNIZATION; FEMALE; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IN VIVO STUDY; LIMIT OF QUANTITATION; LYMPHOCYTE TRANSFER; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL VIRUS INFECTION; VIRUS LOAD; VIRUS PATHOGENESIS; WEIGHT REDUCTION; ADOPTIVE TRANSFER; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; COMPARATIVE STUDY; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LUNG; METABOLISM; PHYSIOLOGY; PNEUMOVIRUS; RESPIRATORY SYSTEM; VACCINATION; VIROLOGY;

ADOPTIVE TRANSFER; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FEMALE; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; LUNG; MICE; MICE, INBRED BALB C; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RESPIRATORY SYSTEM; TUMOR NECROSIS FACTOR-ALPHA; VACCINATION; VACCINES, DNA; VIRAL LOAD; VIRAL VACCINES;

EID: 85038856152     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2017.79     Document Type: Erratum

References (37)

1. Tregoning, J.S. and Schwarze, J. Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. Clin. Microbiol. Rev. 23, 74-98 (2010).
2. Stensballe, L.G., Ravn, H., Kristensen, K., Meakins, T., Aaby, P. and Simoes, E.A. Seasonal variation of maternally derived respiratory syncytial virus antibodies and association with infant hospitalizations for respiratory syncytial virus. J. Pediatr. 154, 296-298 (2009).
3. Piedra, P.A., Jewell, A.M., Cron, S.G., Atmar, R.L. and Glezen, W.P. Correlates of immunity to respiratory syncytial virus (RSV) associatedhospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies. Vaccine 21, 3479-3482 (2003).
4. Habibi, M.S. et al. Impaired antibody-mediated protection and defective IgA B-cell memory in experimental infection of adults with respiratory syncytial virus. Am. J. Respir. Crit. Care Med. 191, 1040-1049 (2015).
5. Hall, C.B. et al. Respiratory syncytial viral infection in children with compromised immune function. N. Engl. J. Med. 315, 77-81 (1986).
6. Tregoning, J.S., Yamaguchi, Y., Harker, J.,Wang, B. and Openshaw, P.J. The role of T cells in the enhancement of respiratory syncytial virus infection severity during adult reinfection of neonatally sensitized mice. J. Virol. 82, 4115-4124 (2008).
7. Graham, B.S., Bunton, L.A., Wright, P.F. and Karzon, D.T. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J. Clin. Invest. 88, 1026-1033 (1991).
8. Openshaw, P.J. and Tregoning, J.S. Immune responses and disease enhancement during respiratory syncytial virus infection. Clin. Microbiol. Rev. 18, 541-555 (2005).
9. Lauvau, G., Boutet, M., Williams, T.M., Chin, S.S. and Chorro, L. Memory CD8+ Tcells: innate-like sensors and orchestrators of protection. Trends Immunol. 37, 375-385 (2016).
10. Mueller, S.N. and Mackay, L.K. Tissue-resident memory T cells: local specialists in immune defence. Nat. Rev. Immunol. 16, 79-89 (2016).
11. Frost, E.L., Kersh, A.E., Evavold, B.D. and Lukacher, A.E. Cutting edge: resident memory CD8 Tcells express high-affinity TCRs. J. Immunol. 195, 3520-3524 (2015).
12. Schenkel, J.M., Fraser, K.A., Beura, L.K., Pauken, K.E., Vezys, V. and Masopust,D. Tcell memory. Residentmemory CD8Tcells trigger protective innate and adaptive immune responses. Science 346, 98-101 (2014).
13. Purwar, R., Campbell, J., Murphy, G., Richards, W.G., Clark, R.A. and Kupper, T.S. Resident memory T cells (T(RM)) are abundant in human lung: diversity, function, and antigen specificity. PLoS ONE 6, e16245 (2011).
14. Jozwik, A. et al. RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection. Nat. Commun. 6, 10224 (2015).
15. Teijaro, J.R., Turner, D., Pham, Q., Wherry, E.J., Lefrancois, L. and Farber, D.L. Cutting edge: tissue-retentive lung memory CD4 T cells mediate optimal protection to respiratory virus infection. J. Immunol. 187, 5510-5514 (2011).
16. Thawer, S.G. et al. Lung-resident CD4(+) T cells are sufficient for IL-4Ralpha-dependent recall immunity to Nippostrongylus brasiliensis infection. Mucosal Immunol. 7, 239-248 (2014).
17. Russell, R.F., McDonald, J.U., Ivanova, M., Zhong, Z., Bukreyev, A. and Tregoning, J.S. Partial attenuation of respiratory syncytial virus with a deletion of a small hydrophobic gene is associated with elevated interleukin-1beta responses. J. Virol. 89, 8974-8981 (2015).
18. Wakim, L.M., Smith, J., Caminschi, I., Lahoud, M.H. and Villadangos, J.A. Antibody-targeted vaccination to lung dendritic cells generates tissueresident memory CD8 T cells that are highly protective against influenza virus infection. Mucosal Immunol. 8, 1060-1071 (2015).
19. Tregoning, J.S. and Kinnear, E. Using plasmids as DNA vaccines for infectious diseases. Microbiol. Spectr. 2, 1-16 (2014).
20. Morabito, K.M., Ruckwardt, T.R., Redwood, A.J., Moin, S.M., Price, D.A. and Graham, B.S. Intranasal administration of RSV antigen-expressing MCMV elicits robust tissue-resident effector and effector memory CD8+ Tcells in the lung. Mucosal Immunol. 10, 545-554 (2016).
21. Tregoning, J.S. et al. The chemokine MIP1alpha/CCL3 determines pathology in primary RSV infection by regulating the balance of T cell populations in the murine lung. PLoS ONE 5, e9381 (2010).
22. Lee, D.C. et al.CD25+ natural regulatory Tcells are critical in limiting innate and adaptive immunity and resolving disease following respiratory syncytial virus infection. J. Virol. 84, 8790-8798 (2010).
23. Goritzka, M. et al. Alveolar macrophage-derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes. J. Exp. Med. 212, 699-714 (2015).
24. Ariotti, S. et al. Tissue-resident memory CD8+ Tcells continuously patrol skin epithelia to quickly recognize local antigen. Proc. Natl. Acad. Sci. USA 109, 19739-19744 (2012).
25. Wu, T. et al. Lung-residentmemory CD8 Tcells (TRM) are indispensable for optimal cross-protection against pulmonary virus infection. J. Leukoc. Biol. 95, 215-224 (2014).
26. Mackay, L.K. et al. The developmental pathway for CD103(+)CD8+ tissue-resident memory Tcells of skin. Nat Immunol 14, 1294-1301 (2013).
27. Kinnear, E.,Caproni, L.J. and Tregoning, J.S. A comparison of red fluorescent proteins to modelDNAvaccine expression bywhole animal in vivo imaging. PLoS ONE 10, e0130375 (2015).
28. Bivas-Benita, M. et al. Airway CD8(+) T cells induced by pulmonary DNA immunization mediate protective anti-viral immunity. Mucosal Immunol. 6, 156-166 (2013).
29. Cuburu, N. et al. Intravaginal immunization with HPV vectors induces tissue-resident CD8+ T cell responses. J. Clin. Invest. 122, 4606-4620 (2012).
30. Shin, H. and Iwasaki, A. A vaccine strategy that protects against genital herpes by establishing local memory Tcells. Nature 491, 463-467 (2012).
31. Tregoning, J.S., Buffa, V.,Oszmiana, A., Klein,K.,Walters,A.A. & Shattock, R.J.A. "prime-pull" vaccine strategy has a modest effect on local and systemic antibody responses to HIV gp140 in mice. PLoS ONE 8, e80559 (2013).
32. Tregoning, J.S. et al. Genetic susceptibility to the delayed sequelae of neonatal respiratory syncytial virus infection is MHC dependent. J. Immunol. 185, 5384-5391 (2010).
33. Saso, A. and Kampmann, B. Vaccination against respiratory syncytial virus in pregnancy: a suitable tool to combat global infant morbidity and mortality?. Lancet Infect. Dis. 16, e153-e163 (2016).
34. Anderson, K.G. et al. Intravascular staining for discrimination of vascular and tissue leukocytes. Nat. Protoc. 9, 209-222 (2014).
35. Donnelly, L. et al. Intravaginal immunization using the recombinant HIV-1 clade-C trimeric envelope glycoprotein CN54gp140 formulated within lyophilized solid dosage forms. Vaccine 29, 4512-4520 (2011).
36. Harker, J., Bukreyev, A., Collins, P.L., Wang, B., Openshaw, P.J. and Tregoning, J.S. Virally delivered cytokines alter the immune response to future lung infections. J. Virol. 81, 13105-13111 (2007).
37. Cheeseman, H.M. et al. Expression profile of human Fc receptors in mucosal tissue: implications for antibody-dependent cellular effector functions targeting HIV-1 transmission. PLoS ONE 11, e0154656 (2016).